Trial intelligence / Profile preview

Endoscopic safety analysis of oral risedronate in adults with liver cirrhosis, esophageal varices, and low bone mass

RBR-76pm35Recruiting

Sponsor
São Paulo Research Foundation
Start
Dec 2013
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of risedronate in osteoporosis and osteopenia (2 arms), sponsored by São Paulo Research Foundation. Primary endpoint: Risk of upper gastrointestinal bleeding. Started Dec 2013; status: recruiting.

02

Drugs

risedronate
03

Conditions

osteoporosisosteopenia

Beyond the preview

Go deeper on RBR-76pm35.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-76pm35.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call